Suxamethon SAD

Suxamethon SAD may be available in the countries listed below.

Ingredient matches for Suxamethon SAD

Suxamethonium Chloride

Suxamethonium Chloride is reported as an ingredient of Suxamethon SAD in the following countries:

• Denmark

International Drug Name Search

Libilister

Libilister may be available in the countries listed below.

Ingredient matches for Libilister

Camostat

Camostat mesilate (a derivative of Camostat) is reported as an ingredient of Libilister in the following countries:

• Japan

International Drug Name Search

Diclobion

Diclobion may be available in the countries listed below.

Ingredient matches for Diclobion

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclobion in the following countries:

• Poland

International Drug Name Search

Mitocortyl

Mitocortyl may be available in the countries listed below.

Ingredient matches for Mitocortyl

Hydrocortisone

Hydrocortisone is reported as an ingredient of Mitocortyl in the following countries:

• France

International Drug Name Search

Gestodène / Ethinylestradiol Ratiopharm

Gestodène/Ethinylestradiol Ratiopharm may be available in the countries listed below.

Ingredient matches for Gestodène/Ethinylestradiol Ratiopharm

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Gestodène/Ethinylestradiol Ratiopharm in the following countries:

• France

Gestodene

Gestodene is reported as an ingredient of Gestodène/Ethinylestradiol Ratiopharm in the following countries:

• France

International Drug Name Search

Sol.No.37 Manitol

Sol.No.37 Manitol may be available in the countries listed below.

Ingredient matches for Sol.No.37 Manitol

Mannitol

Mannitol is reported as an ingredient of Sol.No.37 Manitol in the following countries:

• Venezuela

International Drug Name Search

Pyridoxal

Pyridoxal may be available in the countries listed below.

Ingredient matches for Pyridoxal

Pyridoxal Phosphate

Pyridoxal Phosphate is reported as an ingredient of Pyridoxal in the following countries:

• Japan

International Drug Name Search

Altace

Altace is a brand name of ramipril, approved by the FDA in the following formulation(s):

ALTACE (ramipril - capsule; oral)

• 
  Manufacturer: KING PHARMS
  
  Approval date: January 28, 1991
  
  Strength(s): 1.25MG ^[AB], 10MG ^[RLD][AB], 2.5MG ^[AB], 5MG ^[AB]

Has a generic version of Altace been approved?

A generic version of Altace has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Altace and have been approved by the FDA:

ramipril capsule; oral

• 
  Manufacturer: APOTEX
  
  Approval date: June 20, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA LTD
  
  Approval date: June 8, 2011
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: CIPLA
  
  Approval date: August 7, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: June 18, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: INVAGEN PHARMS
  
  Approval date: June 18, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: LUPIN
  
  Approval date: June 9, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: March 6, 2009
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: June 18, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: June 18, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: June 18, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: October 24, 2005
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA
  
  Approval date: September 2, 2008
  
  Strength(s): 1.25MG ^[AB], 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Altace. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
  Patent 5,403,856
  Issued: April 4, 1995
  Inventor(s): Henning; Rainer & Urbach; Hansjorg & Teetz; Volker & Geiger; Rolf & Scholkens; Bernward
  Assignee(s): Hoechst Aktiengesellschaft
  The invention relates to a method of treating cardiac insufficiency by using compounds of the formula I ##STR1## in which n is 1 or 2, R, R.sup.1, R.sup.2 and R.sup.3 are identical or different and each denote hydrogen or an organic radical and R.sup.4 R.sup.5, together with the atoms carrying them, form a mono-, bi- or tri-cyclic heterocyclic ring system. The invention furthermore relates to compounds of the formula I and agents containing these for use in the treatment of the abovementioned disease.
  
  Patent expiration dates:
  
  
  • April 4, 2012
    
    ✓ 
    Patent use: METHOD OF TREATMENT OF HEART FAILURE
  
  



• 
  Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
  Patent 7,368,469
  Issued: May 6, 2008
  Inventor(s): Schölkens; Bernward & Bender; Norbert & Rangoonwala; Badrudin & Dagenais; Gilles & Gerstein; Hertzel & Yusuf; Salim
  Assignee(s): Sanofi-Aventis Deutschland GmbH
  Use of an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin, in the manufacture of a medicament for the prevention of cardiovascular events; a method of preventing cardiovascular events comprising administering to a patient in need of such prevention an effective amount of an inhibitor of the renin angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin; and a combination product containing an an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof and a cholesterol lowering agent.
  
  Patent expiration dates:
  
  
  • August 30, 2020
    
    ✓ 
    Patent use: METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH
  
  

See also...

• Altace Consumer Information (Drugs.com)
• Altace Consumer Information (Wolters Kluwer)
• Altace Capsules Consumer Information (Wolters Kluwer)
• Altace Consumer Information (Cerner Multum)
• Altace Advanced Consumer Information (Micromedex)
• Altace AHFS DI Monographs (ASHP)
• Ramipril Consumer Information (Drugs.com)
• Ramipril Consumer Information (Wolters Kluwer)
• Ramipril Capsules Consumer Information (Wolters Kluwer)
• Ramipril Consumer Information (Cerner Multum)
• Ramipril Advanced Consumer Information (Micromedex)
• Ramipril AHFS DI Monographs (ASHP)

Cyprest

Cyprest may be available in the countries listed below.

Ingredient matches for Cyprest

Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cyprest in the following countries:

• Poland

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Cyprest in the following countries:

• Poland

International Drug Name Search

Nifedipin Heumann

Nifedipin Heumann may be available in the countries listed below.

Ingredient matches for Nifedipin Heumann

Nifedipine

Nifedipine is reported as an ingredient of Nifedipin Heumann in the following countries:

• Germany

International Drug Name Search

Acetaminophen and Codeine Phosphate

Ingredient matches for Acetaminophen and Codeine Phosphate

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Acetaminophen and Codeine Phosphate in the following countries:

• United States

Paracetamol

Paracetamol is reported as an ingredient of Acetaminophen and Codeine Phosphate in the following countries:

• United States

International Drug Name Search

Profenil

Profenil may be available in the countries listed below.

Ingredient matches for Profenil

Alverine

Alverine citrate (a derivative of Alverine) is reported as an ingredient of Profenil in the following countries:

• Hong Kong

International Drug Name Search

Zapto-CO

Zapto-CO may be available in the countries listed below.

Ingredient matches for Zapto-CO

Captopril

Captopril is reported as an ingredient of Zapto-CO in the following countries:

• South Africa

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Zapto-CO in the following countries:

• South Africa

International Drug Name Search